https://alsnewstoday.com/news/early-cnm-au8-treatment-als-continues-show-survival-benefits/
Early CNM-Au8 treatment continues to demonstrate survival benefits for early ALS patients in a Phase 2 clinical trial and its extension.
Create an account or login to join the discussion